Medical Equipment

Digital Neuro Biomarkers Industry Poised for Rapid Growth, Forecast to Touch $3.18 Billion by 2030 at 27.2% CAGR

May 8, 2026May 11, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the digital neuro biomarkers market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Digital Neuro Biomarkers Market?

The digital neuro biomarkers market has shown substantial expansion in recent years. Its value is predicted to climb from $0.95 billion in 2025 to $1.22 billion in 2026, achieving a compound annual growth rate (CAGR) of 27.5%. The historical growth of this market can be linked to the increasing occurrence of neurological disorders, the wider adoption of wearable devices, a greater focus on cognitive assessment, breakthroughs in neuroimaging technologies, and initial investigations into digital biomarker development.

The digital neuro biomarkers market is anticipated to experience significant expansion over the coming years, with its size projected to reach $3.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 27.2%. This expansion during the projection period stems from several factors, including the increasing application of artificial intelligence in neurological diagnostics, a rising need for remote patient observation, the broadening of tele-neurology offerings, increased funding in neuroscience studies, and the creation of customized neurology treatments. Key developments expected within this forecast period involve more extensive use of cloud-based neurological data analytics, the implementation of real-time brain monitoring systems, the proliferation of mobile cognitive assessment tools, the incorporation of machine learning into biomarker analysis, and the advancement of platforms for predictive and precision neurology.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30571&type=smp

What Drivers Are Supporting Technological Adoption In The Digital Neuro Biomarkers Market?

The heightened emphasis on promptly identifying and tracking neurological disorders is set to fuel the expansion of the digital neuro biomarkers market. This early identification and tracking utilize digital tools like wearable gadgets, mobile applications, and sensors for ongoing evaluation of neurological function, cognitive abilities, and behavior, allowing for prompt recognition of these conditions. Such attention is growing stronger, driven by public health programs and clinical objectives focused on detecting cognitive decline and neurodegenerative illnesses prior to the manifestation of advanced symptoms. Digital neuro biomarkers aid these endeavors by providing unbiased, live data, assisting clinicians and researchers in pinpointing subtle neurological shifts and implementing timely interventions. For example, the U.S. Centres for Disease Control and Prevention’s Healthy Brain Initiative indicated in 2024 that roughly one billion people worldwide suffer from neurological disorders, with about 50 million experiencing epilepsy and 24 million living with Alzheimer’s disease. Consequently, the growing focus on the early detection and ongoing monitoring of neurological disorders via digital instruments is propelling the expansion of the digital neuro biomarkers market.

What Segment Types Are Examined In The Digital Neuro Biomarkers Market?

The digital neuro biomarkers market covered in this report is segmented –

1) By Type: Wearable, Mobile-Based Applications, Sensors, Other Types

2) By Deployment Mode: Cloud-Based Platforms, On-Premise Platforms, Hybrid Deployment Models

3) By Biomarker Type: Cognitive Digital Biomarkers, Motor Function Digital Biomarkers, Speech And Language Digital Biomarkers, Behavioral Digital Biomarkers

4) By End-User: Healthcare Companies, Healthcare Providers, Payers, Other End-Users

Subsegments:

1) By Wearable: Smart Wristbands, Smart Headbands, Smart Watches, Smart Clothing, Implantable Devices

2) By Mobile-Based Applications: Cognitive Assessment Applications, Neurological Monitoring Applications, Mental Health Tracking Applications, Motor Function Assessment Applications, Speech And Language Tracking Applications

3) By Sensors: Electroencephalography Sensors, Electrocardiography Sensors, Eye Tracking Sensors, Motion Tracking Sensors, Biometric Monitoring Sensors

4) By Other Types: Cloud Based Platforms, Data Analytics Tools, Digital Therapeutic Platforms, Artificial Intelligence Enabled Assessment Tools, Virtual Reality Based Assessment Tools

Which Trends Are Shaping Activity Within The Digital Neuro Biomarkers Market?

Major companies operating in the digital neuro biomarkers market are focusing on establishing open-access research infrastructure, such as WearGait PD, to aid in the development, validation, and regulatory assessment of wearable-based digital neuro biomarkers for neurological disorders. WearGait PD is a regulatory science dataset that provides synchronized wearable sensor and gait data from individuals with Parkinson’s disease and age-matched controls, enabling the extraction and evaluation of gait-derived digital biomarkers for disease monitoring and progression assessment. For instance, in July 2024, the U.S. Food and Drug Administration (FDA), a U.S.-based regulatory agency, published WearGait PD: Wearables Dataset for Gait in Parkinson’s Disease and Age-Matched Controls, an open-access dataset designed to support researchers and industry developers in deriving and validating digital biomarkers. This dataset includes raw inertial measurement unit (IMU) acceleration and rotational velocity data, insole pressure recordings, and synchronized gait annotations, facilitating algorithm testing, metric validation, and the development of wearable sensor-based monitoring tools.

Who Are The Top-Performing Companies In The Digital Neuro Biomarkers Market In Recent Years?

Major companies operating in the digital neuro biomarkers market are F. Hoffmann-La Roche AG, Merck KGaA, Biogen Inc., Evidation Health Inc., Huma Therapeutics Limited, Altoida Inc, Cogstate Limited, Quibim S.L., Empatica Inc., Linus Health Inc., Cambridge Cognition Holdings plc, Brainomix Limited, Mindstrong Health Inc., Neurotrack Technologies Inc., Feel Therapeutics Inc., BrainCheck Inc., IXICO plc, NeuraMetrix Inc., NeuraLight Ltd., Koneksa Health Inc., Sonde Health Inc., Aural Analytics Inc., Winterlight Labs Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/digital-neuro-biomarkers-market-report

Which Region Currently Holds The Largest Share Of The Digital Neuro Biomarkers Market?

North America was the largest region in the digital neuro biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital neuro biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Digital Neuro Biomarkers Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30571&type=smp

Browse Through More Reports Similar to the Global Digital Neuro Biomarkers Market 2026, By The Business Research Company

Neurological Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

Central Nervous System Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report

clinical biomarkers global market report

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795